Introduction:
Sandoz, a global leader in generic and biosimilar medicines, opens new production facility in Kundl, Austria.
Features:
Facility aims to provide affordable life-saving drugs solely manufactured in Europe, catering to a larger patient base.
Automated production lines boost capacity by 20% compared to current levels.
Focus on antibiotics underscores resilience of European manufacturing.
Facility spans 3,000m² and integrates innovative technologies for increased production.
Additional production includes one billion penicillin tablets and doubled powder oral suspensions (POS), crucial for pediatric medicines.
Demonstrates Sandoz's commitment to Austria as integral part of European production network.
Kundl serves as hub for Sandoz's vertically integrated penicillin production in Europe.
Investment addresses antibiotic shortages, enhances patient access to essential medicines.
Specifications:
Name Sandoz
Type Construction
